First Experience of Optimization of Tacrolimus Therapeutic Drug Monitoring in a Patient Cotreated With Nirmatrelvir/Ritonavir: How Microsampling Approach Changes Everything

Léonard Golbin; Camille Tron; Bénédicte Franck; Cécile Vigneau; Marie-Clémence Verdier; Florian Lemaitre

doi:10.1097/TP.0000000000004430

First Experience of Optimization of Tacrolimus Therapeutic Drug Monitoring in a Patient Cotreated With Nirmatrelvir/Ritonavir: How Microsampling Approach Changes Everything

Transplantation. 2023 Feb 1;107(2):e68-e69. doi: 10.1097/TP.0000000000004430. Epub 2023 Jan 26.

Authors

Léonard Golbin^{1

2}, Camille Tron^{2

3

4}, Bénédicte Franck^{2

3

4}, Cécile Vigneau^{1

2

3

4}, Marie-Clémence Verdier^{2

3

4}, Florian Lemaitre^{2

3

4}

Affiliations

¹ Nephrology Department, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Service de Néphrologie, Rennes, France.
² Fédération Hospitalo-Universitaire Survival Optimization in Organ Transplantation, Rennes, France.
³ University of Rennes, Centre Hospitalier Universitaire Rennes, École des Hautes Études en Santé Publique, IRSET (Institut de Recherche en Santé, Environnement et Travail), UMR S 1085, Rennes, France.
⁴ INSERM, Centre d'Investigation Clinique 1414, Rennes, France.

PMID: 36696522
DOI: 10.1097/TP.0000000000004430

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Drug Monitoring
Humans
Ritonavir* / therapeutic use
Tacrolimus* / adverse effects

Substances

Ritonavir
nirmatrelvir
Tacrolimus